Angiogenesis and Mast Cells in Non-Hodgkin's Lymphoma: A Strong Correlation in Angioimmunoblastic T-Cell Lymphoma

References

• Dvorak F. H., Brown F. L., Detmar M., Dvorak A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology 1995; 146: 1029–1039
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1995; 1: 27–31
   PubMed Web of Science ®Google Scholar
• Warnke R. A., Weiss L. M., Chan J. K. C. Tumors of the Lymph Nodes and Spleen. Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC 1995, Third Series. Fascicle 14
   Google Scholar
• Aozasa K., Ohsawa M., Fujita M. Q., Kanayama Y., Tominaga N., Yonezawa T., Matsubuchi T., Hirata M., Uda H., Kanamaru A., Inada E., Nakayama S. Angioimmunoblastic lymphadenopathy. Review of 44 patients with emphasis on prognostic behavior. Cancer 1989; 63: 1625–1629
   PubMed Web of Science ®Google Scholar
• Sallah S., Gagnon A. G. Angioimmunoblastic lymphadenopathy with dysproteinemia: Emphasis on pathogenesis and treatment. Acta Haematologica 1998; 99: 57–64
   PubMed Web of Science ®Google Scholar
• Chan A. S., Leung S. Y., Wong M. P., et al. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. American Journal of Surgical Pathology 1998; 22: 816–826
   PubMed Web of Science ®Google Scholar
• Dellian M., Witwer B. P., Salehi H. A., Yuan F., Jain R. K. Quantitation and physiological characterization of angiogenetic vessels in mice. Effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor and host microenvironment. American Journal of Pathology 1996; 149: 59–71
   PubMed Web of Science ®Google Scholar
• Konerding M. A., Fait E., Dimitropoulou C., Malkusch W., Ferri C., Giavazzi R., Coltrini D., Presta M. Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study. American Journal of Pathology 1998; 152: 1607–1616
   PubMed Web of Science ®Google Scholar
• Meininger J. C., Zetter B. R. Mast cell and angiogenesis. Seminars in Cancer Biology 1992; 3: 73–79
   PubMedGoogle Scholar
• Meininger J. C. Mast cell and Tumor-associated angiogenesis. Chemical Immunology 1995; 62: 239–257
   PubMed Web of Science ®Google Scholar
• Yamada T., Sawatsubashi M., Yakushiji H., Itoh Y., Edakuni G., Mori M., Robert L., Miyazaki K. Localization of vascular endothelial growth factor in synovial membrane mast cells: examination with “multi-labelling subtraction immunostaining”. Virchows Archiv 1998; 433: 567–570
   PubMed Web of Science ®Google Scholar
• Sawatsubashi M., Yamada T., Fukushima N., Mizokami H., Tokunaga O., Shin T. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Archiv 2000; 436: 243–248
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Sharma V. K., Agrawal A., Pratap V. K., Nagar A. M., Mehrotra M. L. Mast cell reactivity in lymphoma: a preliminary communication. Indian Journal of Cancer 1992; 29: 61–65
   PubMedGoogle Scholar
• Satodate R., Schwarze E. W., Lennert K. Tissue mast cell count in immunocytoma and chronic lymphocytic leukaemia. [Article in German]. Virchows Arch A Pathol Anat Histol 1977; 373: 303–309
   PubMed Web of Science ®Google Scholar
• Ohshima K., Kikuchi M., Hashimoto M., Kozuru M., Uike N., Kobari S., Masuda Y., Sumiyoshi Y., Yoneda S., Takeshita M., Kimura N. Genetic changes in atypical hyperplasia and lymphoma with angioimmunoblastic lymphadenopathy and dysproteinaemia in the same patients. Virchows Archiv 1994; 425: 25–32
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Strickler J. G., Dorfman R. F., Horning S. J., Warnke R. A., Sklar J. Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. American Journal of Pathology 1986; 122: 392–397
   PubMed Web of Science ®Google Scholar
• Ribatti D., Nico B., Vacca A., Marzullo A., Calvi N., Roncali L., Dammacco F. Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas?. British Journal of Cancer 1997; 77: 1900–1906
   Web of Science ®Google Scholar
• Ribatti D., Vacca A., Marzullo A., Nico B., Ria R., Roncali L., Dammacco F. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. International Journal of. Cancer 2000; 85: 171–175
   Web of Science ®Google Scholar
• Ribatti D., Vacca A., Nico B., Quondamatteo F., Ria R., Minischetti M., Marzullo A., Herken R., Roncali L., Dammacco F. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. British Journal of Cancer 1999; 79: 451–455
   PubMed Web of Science ®Google Scholar
• Grutzkau A., Kruger-Krasagakes S., Baumeister H., Schwarz C., Kogel H., Welker P., Lippert U., Henz B. M., Moller A. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Molecular Biology of the Cell 1998; 9: 875–878
   PubMed Web of Science ®Google Scholar
• Kim K. J., Li B., Winer J., Armanini M., Gillett N., Phillips H. S., Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993; 362: 841–844
   PubMed Web of Science ®Google Scholar
• Millauer B., Shawver L. K., Plate K. H., Risau W., Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994; 367: 576–579
   PubMed Web of Science ®Google Scholar
• Bellamy W. T., Richter L., Frutiger Y., Grogan T. M. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Research 1999; 59: 28–733
   PubMed Web of Science ®Google Scholar
• Foss H. D., Araujo I., Demel G., Klotzbach H., Hummel M., Stein H. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. Journal of Pathology 1997; 183: 44–50
   PubMed Web of Science ®Google Scholar
• Blair R. J., Meng H., Marchese M. J., Ren S., Schwartz L. B., Tonnesen M. G., Gruber B. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. Journal of Clinical Investigation 1997; 99: 2691–2700
   PubMed Web of Science ®Google Scholar
• Ohshima K., Sugihara M., Suzumiya J., Haraoka S., Kanda M., Shimazaki K., Katoh K., Kumagawa M., Kikuchi M. Basic fibroblast growth factor and fibrosis in Hodgkin's disease. Pathology Research and Practice 1999; 195: 149–155
   PubMed Web of Science ®Google Scholar
• Broudy C. V. Stem cell factor and hematopoiesis. Blood 1997; 90: 1345–1364
   PubMed Web of Science ®Google Scholar
• Hsu S. M., Hsu P. L. Autocrine and paracrine functions of cytokines in malignant lymphomas. Biomed and pharmacother 1994; 48: 433–444
   PubMed Web of Science ®Google Scholar
• Merz H., Fliedner A., Orscheschek K., Binder T., Sebald W., Muller-Hermelink H. K., Feller A. C. Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. American Journal of Pathology 1991; 139: 1173–1180
   PubMed Web of Science ®Google Scholar